Search - tctmd.com

Displaying 1 - 14 of 14

Sort: Relevancy | Date

News Daily News

FDA Warns of Air Embolism Risk With Watchman LAAO Access Systems

Todd Neale

August 06, 2025

News Daily News

Reduced Shock Efficacy With Some Boston Scientific Defibrillation Leads

Todd Neale

August 06, 2025

News Daily News

FDA Issues Safety Communication for Some Accolade Pacemakers

L.A. McKeown

December 16, 2024

News Opinion Off Script

Evoque and Patisiran: A Tale of Two Regulatory Journeys

Sanjay Kaul, MD

March 29, 2024

News Daily News

‘Overwhelming Reduction’ in Bleeding With Abelacimab vs Rivaroxaban in AF

L.A. McKeown

September 18, 2023

News Daily News

FDA Investigating Possible Sex Differences in LAAO Outcomes

Todd Neale

September 27, 2021

News Daily News

FDA Issues Class I Recall for Emblem S-ICD Over Electrode Fractures

Michael O'Riordan

February 12, 2021

News Daily News

Lotus Edge TAVR Device Recalled and Discontinued Worldwide

Michael O'Riordan

November 18, 2020

News Daily News

FDA Class I Recall for Boston Scientific’s IMAGER II Angiographic Catheters

L.A. McKeown

April 07, 2020

News Conference News

ACC, EHRA Cancel 2020 Meetings Over COVID-19

Michael O'Riordan

March 09, 2020

News Daily News

FDA Advisors Recommend CVD Event Reduction Claim for Icosapent Ethyl

Michael O'Riordan

November 14, 2019

News Daily News

Boston Scientific Recalls All Lotus Valves, Including Lotus With Depth Guard

Michael O'Riordan

February 23, 2017

News Daily News

Boston Scientific Announces Fix for Lotus Edge TAVR Device Following Implantation ‘Pause’

L.A. McKeown

January 11, 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2016

Caitlin E. Cox

September 01, 2016

Advertisement

FDA Warns of Air Embolism Risk With Watchman LAAO Access Systems

Reduced Shock Efficacy With Some Boston Scientific Defibrillation Leads

FDA Issues Safety Communication for Some Accolade Pacemakers

Evoque and Patisiran: A Tale of Two Regulatory Journeys

‘Overwhelming Reduction’ in Bleeding With Abelacimab vs Rivaroxaban in AF

FDA Investigating Possible Sex Differences in LAAO Outcomes

FDA Issues Class I Recall for Emblem S-ICD Over Electrode Fractures

Lotus Edge TAVR Device Recalled and Discontinued Worldwide

FDA Class I Recall for Boston Scientific’s IMAGER II Angiographic Catheters

ACC, EHRA Cancel 2020 Meetings Over COVID-19

FDA Advisors Recommend CVD Event Reduction Claim for Icosapent Ethyl

Boston Scientific Recalls All Lotus Valves, Including Lotus With Depth Guard

Boston Scientific Announces Fix for Lotus Edge TAVR Device Following Implantation ‘Pause’

TCTMD’s Top 10 Most Popular Stories for August 2016

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content